<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font18">CMV </span>
   <span class="font18">for </span>
   <span class="font14">[]. </span>
   <span class="font14">cytomegalovirus </span>
   <span class="font14">with </span>
   <span class="font14">viral </span>
   <span class="font13">The </span>
   <span class="font13">are </span>
   <span class="font13">that </span>
   <span class="font13">{background </span>
   <span class="font12">which </span>
   <span class="font12">HCMV </span>
   <span class="font12">infection </span>
   <span class="font12">cell </span>
   <span class="font12">antiviral </span>
   <span class="font12">congenital </span>
   <span class="font12">infections </span>
   <span class="font12">margin </span>
   <span class="font12">{border-style </span>
   <span class="font11">cells </span>
   <span class="font11">immune </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">human </span>
   <span class="font11">against </span>
   <span class="font11">can </span>
   <span class="font11">has </span>
   <span class="font11">specific </span>
   <span class="font11">DNA </span>
   <span class="font11">latency </span>
   <span class="font11">target </span>
   <span class="font11">been </span>
   <span class="font11">gene </span>
   <span class="font11">have </span>
   <span class="font11">was </span>
   <span class="font11">EGS </span>
   <span class="font11">clinical </span>
   <span class="font11">genome </span>
   <span class="font11">latent </span>
   <span class="font11">system </span>
   <span class="font11">al. </span>
   <span class="font11">drugs </span>
   <span class="font11">including </span>
   <span class="font11">organ </span>
   <span class="font11">proteins </span>
   <span class="font11">such </span>
   <span class="font11">vaccine </span>
   <span class="font11">CRISPR/Cas </span>
   <span class="font11">cause </span>
   <span class="font11">early </span>
   <span class="font11">effective </span>
   <span class="font11">host </span>
   <span class="font11">replication </span>
   <span class="font11">this </span>
   <span class="font11">treatment </span>
   <span class="font11">used </span>
   <span class="font10">from </span>
   <span class="font10">genes </span>
   <span class="font10">infections. </span>
   <span class="font10">natural </span>
   <span class="font10">recipients </span>
   <span class="font10">sequence </span>
   <span class="font10">still </span>
   <span class="font10">therapeutic </span>
   <span class="font10">transplant </span>
   <span class="font10">were </span>
   <span class="font10">Infect. </span>
   <span class="font10">[,]. </span>
   <span class="font10">diseases </span>
   <span class="font10">expression </span>
   <span class="font10">maribavir </span>
   <span class="font10">may </span>
   <span class="font10">more </span>
   <span class="font10">new </span>
   <span class="font10">patients </span>
   <span class="font10">protein </span>
   <span class="font10">px; </span>
   <span class="font10">required </span>
   <span class="font10">responses </span>
   <span class="font10">therapy </span>
   <span class="font10">transplantation </span>
   <span class="font10">{font-family </span>
   <span class="font10">ACT </span>
   <span class="font10">MCMV </span>
   <span class="font10">about </span>
   <span class="font10">after </span>
   <span class="font10">agents </span>
   <span class="font10">capsid </span>
   <span class="font10">central </span>
   <span class="font10">font-size </span>
   <span class="font10">hearing </span>
   <span class="font10">immunity </span>
   <span class="font10">major </span>
   <span class="font10">most </span>
   <span class="font10">murine </span>
   <span class="font10">not </span>
   <span class="font10">results </span>
   <span class="font10">strategies </span>
   <span class="font10">strategy </span>
   <span class="font10">their </span>
   <span class="font10">treat </span>
   <span class="font10">variant </span>
   <span class="font10">HHV-, </span>
   <span class="font10">However, </span>
   <span class="font10">RNA </span>
   <span class="font10">RNase </span>
   <span class="font10">TALENs </span>
   <span class="font10">TCM </span>
   <span class="font10">but </span>
   <span class="font10">cells. </span>
   <span class="font10">complex </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">external </span>
   <span class="font10">further </span>
   <span class="font10">guinea </span>
   <span class="font10">hematopoietic </span>
   <span class="font10">infected </span>
   <span class="font10">infection: </span>
   <span class="font10">lytic </span>
   <span class="font10">primary </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">reactivation </span>
   <span class="font10">showed </span>
   <span class="font10">targeting </span>
   <span class="font10">through </span>
   <span class="font10">viruses </span>
   <span class="font10">Cytomegalovirus </span>
   <span class="font10">Med. </span>
   <span class="font10">This </span>
   <span class="font10">Virol../j.jcv... </span>
   <span class="font10">active </span>
   <span class="font10">approved </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">both </span>
   <span class="font10">compared </span>
   <span class="font10">could </span>
   <span class="font10">during </span>
   <span class="font10">efficacy </span>
   <span class="font10">following </span>
   <span class="font10">guide </span>
   <span class="font10">immediate </span>
   <span class="font10">its </span>
   <span class="font10">mRNA </span>
   <span class="font10">nervous </span>
   <span class="font10">other </span>
   <span class="font10">phase </span>
   <span class="font10">pig </span>
   <span class="font10">promising </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">tegument </span>
   <span class="font10">these </span>
   <span class="font10">transcription </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(CMV) </span>
   <span class="font10">Clin </span>
   <span class="font10">Letermovir </span>
   <span class="font10">SOT </span>
   <span class="font10">Though </span>
   <span class="font10">[,,]. </span>
   <span class="font10">activator-like </span>
   <span class="font10">adoptive </span>
   <span class="font10">al.Letermovir </span>
   <span class="font10">allogeneic </span>
   <span class="font10">also </span>
   <span class="font10">and/or </span>
   <span class="font10">anti-HCMV </span>
   <span class="font10">application </span>
   <span class="font10">bold </span>
   <span class="font10">candidate </span>
   <span class="font10">caused </span>
   <span class="font10">cells, </span>
   <span class="font10">courier; </span>
   <span class="font10">demonstrated </span>
   <span class="font10">developed </span>
   <span class="font10">editing </span>
   <span class="font10">effects </span>
   <span class="font10">em; </span>
   <span class="font10">engineered </span>
   <span class="font10">envelope </span>
   <span class="font10">essential </span>
   <span class="font10">function </span>
   <span class="font10">growth </span>
   <span class="font10">had </span>
   <span class="font10">healthy </span>
   <span class="font10">hematopoietic-cell </span>
   <span class="font10">higher </span>
   <span class="font10">highly </span>
   <span class="font10">infection, </span>
   <span class="font10">infectionJ. </span>
   <span class="font10">infections, </span>
   <span class="font10">into </span>
   <span class="font10">late </span>
   <span class="font10">likely </span>
   <span class="font10">loss </span>
   <span class="font10">low </span>
   <span class="font10">memory </span>
   <span class="font10">mental </span>
   <span class="font10">might </span>
   <span class="font10">mortality </span>
   <span class="font10">mutants </span>
   <span class="font10">one </span>
   <span class="font10">patients, </span>
   <span class="font10">patients. </span>
   <span class="font10">pentamer </span>
   <span class="font10">plasmids </span>
   <span class="font10">potential </span>
   <span class="font10">precursor </span>
   <span class="font10">prevention </span>
   <span class="font10">problems </span>
   <span class="font10">protection </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor </span>
   <span class="font10">reduction </span>
   <span class="font10">related </span>
   <span class="font10">repeats </span>
   <span class="font10">resistant </span>
   <span class="font10">risk </span>
   <span class="font10">sequences </span>
   <span class="font10">short </span>
   <span class="font10">should </span>
   <span class="font10">solid </span>
   <span class="font10">specifically </span>
   <span class="font10">stem </span>
   <span class="font10">systems </span>
   <span class="font10">than </span>
   <span class="font10">they </span>
   <span class="font10">tool </span>
   <span class="font10">vaccines </span>
   <span class="font10">variants </span>
   <span class="font10">virions </span>
   <span class="font10">weakened </span>
   <span class="font10">would </span>
  </p>
 </body>
</html>
